GB
Sciences Inc (OTCMKTS:GBLX)
says it will unveil some new medical
cannabis products in a matter of months. This business guru believes it is good
to educate Louisiana pharmacists and physicians
about the products. The company’s subsidiary
GB Sciences Louisiana is making preparations to conduct educative seminars
starting August. It will cooperate with the LSU AgCenter and several
state-approved medical cannabis pharmacies in conducting the sessions.

The program

Louisiana’s
medical cannabis program seeks to encourage more active participation of the
pharmacists and physicians in the program. Those that have a direct touch with
cannabis patients at the point of sale will find the program quite useful.

 The number of patients in need of cannabis
products continues to rise with time because of the associated benefits. These
patients will need to make a lot of consultations in order to understand the
product better. The participating parties will be prepared adequately to answer
all questions that might arise.

The President of GB Sciences Louisiana John Davis opines, “We want to help healthcare professionals understand the potency of our formulations, how to best recommend our products and the evidence-based approach that influenced and supports their design and use.”

Dr. Andrea’s thoughts

The Director of GB
Sciences who is also its Chief Science Officer Dr. Andrea
Small-Howard has spoken about the matter. He reveals that they will make
presentations of the placebo-controlled human clinical trial data in a
random way. The target will be to make an illustration of the safety of the
products. Asides from that, they will also be about illustrating the medical
cannabis-based therapies potential efficacy. Experts say that the products will
have to adhere to the approved medical conditions in the state of Louisiana.

Tutorials will also focus on
showcasing the recommended dosage and usage of new
medical cannabis products. Dr. Small-Howard advises cannabis patients to start
by taking low doses of the products initially. As time progresses, they will be
free to increase the dose in bits until they achieve the desired level of
relief. The official says that they will be welcoming more personalized
approaches towards helping patients in need. According to him, the ingredients
in the products have different effects on different patients.